Heska Corporation

Heska Corporation is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Heska Corporation is not a good value stock. Heska Corporation is not very popular among insiders. Heska Corporation is a mediocre stock to choose.
Log in to see more information.
Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty produ...
HSKA Fundamental Data by TradingView

News

Reviewing Heska (NASDAQ:HSKA) and Alphatec (NASDAQ:ATEC)
Reviewing Heska (NASDAQ:HSKA) and Alphatec (NASDAQ:ATEC)

Ticker Report Heska (NASDAQ:HSKA Get Rating) and Alphatec (NASDAQ:ATEC Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, ...\n more…

Head to Head Survey: Heska (NASDAQ:HSKA) & Alphatec (NASDAQ:ATEC)
Head to Head Survey: Heska (NASDAQ:HSKA) & Alphatec (NASDAQ:ATEC)

Zolmax Heska (NASDAQ:HSKA Get Rating) and Alphatec (NASDAQ:ATEC Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, analyst recommendations, risk, institutional ownership ...\n more…

Heska (NASDAQ:HSKA) Coverage Initiated at StockNews.com
Heska (NASDAQ:HSKA) Coverage Initiated at StockNews.com

Ticker Report Equities research analysts at StockNews.com initiated coverage on shares of Heska (NASDAQ:HSKA Get Rating) in a report released on Friday. The firm set a hold rating on the medical research companys stock. A number of other research analysts also recently issued reports ...\n more…

Heska (NASDAQ:HSKA) Now Covered by Analysts at StockNews.com
Heska (NASDAQ:HSKA) Now Covered by Analysts at StockNews.com

Zolmax StockNews.com initiated coverage on shares of Heska (NASDAQ:HSKA Get Rating) in a report released on Friday morning. The brokerage issued a hold rating on the medical research companys stock. A number of other equities analysts have also recently commented on the stock. Alliance Global Partners cut ...\n more…

Heska (NASDAQ:HSKA) Sets New 12-Month High at $119.96
Heska (NASDAQ:HSKA) Sets New 12-Month High at $119.96

Zolmax Shares of Heska Co. (NASDAQ:HSKA Get Rating) reached a new 52-week high on Thursday . The company traded as high as $119.96 and last traded at $119.96, with a volume of 120444 shares trading hands. The stock had previously closed at $119.87. Analyst Upgrades and Downgrades A number of ...\n more…

Heska (NASDAQ:HSKA) Coverage Initiated at StockNews.com
Heska (NASDAQ:HSKA) Coverage Initiated at StockNews.com

Zolmax Equities researchers at StockNews.com began coverage on shares of Heska (NASDAQ:HSKA Get Rating) in a report issued on Thursday. The firm set a hold rating on the medical research companys stock. Other research analysts have also recently issued research reports about the company. Alliance Global ...\n more…